Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
TGTX
#1254
TG Therapeutics, Inc.
34.5
6
USD
+2.28%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.28%
Aylık Değişim
+22.55%
6 aylık değişim
+1.26%
Yıllık Değişim
-10.30%
Önceki Kapanış
33.7
9
Open
34.5
6
Bid
Ask
Low
34.5
6
High
34.5
6
Hacim
90
Piyasalar
ABD Borsası
Sağlık Hizmetleri
TGTX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
140.59 M
142.82 M
146.36 M
154.42 M
157.07 M
159.69 M
—
Valuation ratios
Enterprise value
6.78 B
2.49 B
1.67 B
2.65 B
4.8 B
4.93 B
23.07 B
Price to earnings ratio
—
—
-7.92
189.33
200.67
10.76
276.14
Price to sales ratio
—
—
562.55
10.83
14.67
7.81
48.04
Price to cash flow ratio
—
—
-8.89
-80.56
-119.11
-194.24
-480.03
Price to book ratio
—
—
26.73
15.77
21.7
7.43
25.69
Enterprise value to EBITDA ratio
-24.81
-7.04
-8.35
121.78
108.29
37.94
260.33
Profitability ratios
Return on assets %
-0.45
-0.92
-1.02
0.04
0.04
0.42
0.45
Return on equity %
-0.54
-1.47
-3.39
0.08
0.11
0.69
0.8
Return on invested capital %
-1 649.24
-2 168.43
-1 554.62
145.45
108.67
425.88
421.36
Gross margin %
100
100
100
93.95
88.3
83.66
336.54
Operating margin %
-180 K
-5 154.28
-6 924.2
8.83
12.74
20.01
76.2
EBITDA margin %
-179.28 K
-5 130.75
-6 839.5
8.92
12.76
20.02
76.24
Net margin %
-183.8 K
-5 204.08
-7 121.54
5.42
7.11
72.56
277.85
Liquidity ratios
Quick ratio
—
—
—
5.18
5.03
3.29
12.17
Current ratio
6.99
5.06
3.16
5.92
6.25
4.1
15.81
Inventory turnover
—
—
—
0.35
0.51
0.85
0.7
Asset turnover
0
0.01
0.01
0.89
0.73
0.75
0.78
Solvency ratios
Debt to assets ratio
0.03
0.21
0.43
0.34
0.44
0.24
1.23
Debt to equity ratio
0.04
0.33
1.42
0.69
1.14
0.39
2.8
Long term debt to total assets ratio
0.01
0.18
0.37
0.3
0.42
0.23
1.19
Long term debt to total equity ratio
0.01
0.28
1.21
0.62
1.1
0.38
2.7
Per share metrics
Operating cash flow per share
—
—
-1.3
-0.21
-0.25
-0.15
-0.15
EBIT per share
—
—
-1.42
0.14
0.26
0.76
0.76
EBITDA per share
—
—
-1.41
0.14
0.26
0.76
0.76
Total debt per share
—
—
0.61
0.75
1.58
1.57
6.27
Cash per share
—
—
1.29
1.46
1.94
1.24
5.76
Net current asset value per share
—
—
1.24
2.14
3.53
3.91
15.68
Tangible book value per share
—
—
0.43
1.08
1.39
4.01
10.94
Working capital per share
—
—
0.85
1.78
2.97
2.96
11.71
Book value per share
—
—
0.43
1.08
1.39
4.01
10.94
Haberler
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX)
TG Therapeutics, Blue Owl’dan 750 milyon dolarlık kredi aldı
BRIUMVI yüksek aktif multipl skleroz hastalarında etkinlik gösterdi
BRIUMVI shows efficacy in highly active multiple sclerosis patients
TG Therapeutics nöroloji toplantısında BRIUMVI verilerini sunacak
TG Therapeutics to present BRIUMVI data at neurology meeting
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG kazancı $0,23 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek
TG earnings missed by $0.23, revenue topped estimates
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates